Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota and currently employs 38 full-time employees. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Follow-Up Questions
¿Qué tal es el rendimiento del precio de la acción NUWE?
El precio actual de NUWE es de $3.8, ha increased un 0.67% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Nuwellis Inc?
Nuwellis Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Nuwellis Inc?
La capitalización bursátil actual de Nuwellis Inc es $3.4M
¿Es Nuwellis Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 3 analistas han realizado calificaciones de análisis para Nuwellis Inc, incluyendo 2 fuerte compra, 4 compra, 1 mantener, 0 venta, y 2 fuerte venta
